# GO_molecular_function_0052

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `GO_molecular_function`  
**Author expected answer:** **B** — odorant binding

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | contradicted | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | valid_review |

**Paired comparison:** key differ; reasoning agree. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MSFLFFLVVLISIGLWVGPCVADNPENRCIKQFAKTNPACIVHCKYNLYKFTDDNYDITDQHINKFTDVLIKNKAVDGSKKSQVQEHLKKCAEESLKKTHGKNCQRLVEYYSCAVDNKLIDYFKYESAINSYDRSIYTPPYSG

[Multiple Choices]
A. nicotinate-nucleotide adenylyltransferase activity
B. odorant binding
C. calmodulin binding
D. enzyme inhibitor activity
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Gene Ontology (GO) Molecular Function Prediction, which is to predict the fundamental activity of a protein at the molecular level, as defined by the Gene Ontology (GO) 'Molecular Function' branch. This describes the elemental tasks a protein performs, such as catalysis, transport, or binding to specific molecules. Based on the protein's amino acid sequence, you are to select the option that best describes its primary molecular function.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: contradicted

> For this exact sequence, the record reports experimentally supported inhibition of host coagulation factor XII, which aligns with enzyme inhibitor activity (D). Odorant binding (B) appears only as an InterPro-based computational annotation, so the evidence weighs against B as the primary function.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [C7](#evidence-c7), [H3](#evidence-h3), [H4](#evidence-h4).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The N-terminal hydrophobic segment suggests secretion, and the cysteine-rich sequence is compatible with a small secreted protein; those features do not by themselves distinguish odorant binding from enzyme inhibition.


**Missing item-specific fact**

> The sequence-to-family annotation or experimentally characterized activity for this particular protein is needed to choose among these functions.


**Reason**

> No supplied context or general sequence feature meaningfully distinguishes the options. Identifying an insect odorant-binding-like family or recalling this protein's experimentally characterized inhibitory activity requires protein-specific knowledge not provided in the question.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "B",
  "D"
]
```

> B has a computational InterPro-based annotation, while D is supported by experimental evidence. The evidence does not establish that odorant binding is impossible, but it supports D much more strongly as the primary function.


### Important caveats

- The exact-sequence match is to UniProt entry L0MZ37; the author’s source snapshot is unknown.
- The odorant-binding annotation is computational (IEA:InterPro), whereas the reported inhibitory function has experimental evidence.
- The cited evidence supports inhibition but does not directly test or rule out odorant binding.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The N-terminal hydrophobic segment suggests secretion, and the cysteine-rich sequence is compatible with a small secreted protein; those features do not by themselves distinguish odorant binding from enzyme inhibition.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The sequence-to-family annotation or experimentally characterized activity for this particular protein is needed to choose among these functions.",
    "reason": "No supplied context or general sequence feature meaningfully distinguishes the options. Identifying an insect odorant-binding-like family or recalling this protein's experimentally characterized inhibitory activity requires protein-specific knowledge not provided in the question."
  },
  "case_id": "GO_molecular_function_0052",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "C7",
      "H3",
      "H4"
    ],
    "judgment": "contradicted",
    "reason": "For this exact sequence, the record reports experimentally supported inhibition of host coagulation factor XII, which aligns with enzyme inhibitor activity (D). Odorant binding (B) appears only as an InterPro-based computational annotation, so the evidence weighs against B as the primary function."
  },
  "important_caveats": [
    "The exact-sequence match is to UniProt entry L0MZ37; the author’s source snapshot is unknown.",
    "The odorant-binding annotation is computational (IEA:InterPro), whereas the reported inhibitory function has experimental evidence.",
    "The cited evidence supports inhibition but does not directly test or rule out odorant binding."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "B",
      "D"
    ],
    "reason": "B has a computational InterPro-based annotation, while D is supported by experimental evidence. The evidence does not establish that odorant binding is impossible, but it supports D much more strongly as the primary function."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_molecular_function_0052",
  "expected_answer_check": {
    "judgment": "contradicted",
    "reason": "For this exact sequence, the record reports experimentally supported inhibition of host coagulation factor XII, which aligns with enzyme inhibitor activity (D). Odorant binding (B) appears only as an InterPro-based computational annotation, so the evidence weighs against B as the primary function.",
    "evidence_ids": ["C5", "C6", "C7", "H3", "H4"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The N-terminal hydrophobic segment suggests secretion, and the cysteine-rich sequence is compatible with a small secreted protein; those features do not by themselves distinguish odorant binding from enzyme inhibition.",
    "missing_item_specific_fact": "The sequence-to-family annotation or experimentally characterized activity for this particular protein is needed to choose among these functions.",
    "reason": "No supplied context or general sequence feature meaningfully distinguishes the options. Identifying an insect odorant-binding-like family or recalling this protein's experimentally characterized inhibitory activity requires protein-specific knowledge not provided in the question."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["B", "D"],
    "reason": "B has a computational InterPro-based annotation, while D is supported by experimental evidence. The evidence does not establish that odorant binding is impossible, but it supports D much more strongly as the primary function."
  },
  "important_caveats": [
    "The exact-sequence match is to UniProt entry L0MZ37; the author’s source snapshot is unknown.",
    "The odorant-binding annotation is computational (IEA:InterPro), whereas the reported inhibitory function has experimental evidence.",
    "The cited evidence supports inhibition but does not directly test or rule out odorant binding."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> GO:0005549 (odorant binding) is annotated in UniProt entry L0MZ37 (evidence_id C6/H4). However, this annotation carries evidence code IEA:InterPro, meaning it is a purely computational inference from InterPro domain matching, not experimental evidence. The protein's experimentally validated molecular function (ECO:0000269, PubMed:35817195) is inhibition of coagulation factor XII activation, corresponding to GO:0090729 (toxin activity, IDA) and functionally to enzyme inhibitor activity (option D). The expected answer is technically present in the database but represents a low-confidence automated annotation that contradicts the experimentally determined function.

Citations as saved: [C6](#evidence-c6), [H4](#evidence-h4), [C5](#evidence-c5), [H3](#evidence-h3), [C7](#evidence-c7), [H5](#evidence-h5).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence contains a signal peptide and a ~120-residue mature domain. Without database lookup, a model reasoning from sequence features would identify serpin-like or lipocalin-like structural motifs. The experimental literature (PubMed:35817195) establishes this protein as a coagulation factor XII inhibitor, making 'enzyme inhibitor activity' (D) the biologically accurate answer. The 'odorant binding' label arises solely from an InterPro domain-similarity call (IEA), not from any observable odorant-binding motif in the sequence. No general biological reasoning from the raw sequence would preferentially select 'odorant binding' over 'enzyme inhibitor activity'; in fact, the opposite is more defensible.


**Missing item-specific fact**

> The specific InterPro domain assignment that triggers the IEA:InterPro annotation of GO:0005549 for this exact sequence, and the knowledge that the benchmark authors used the database annotation (including low-confidence IEA entries) as the ground truth rather than the experimentally validated function.


**Reason**

> Selecting 'odorant binding' over 'enzyme inhibitor activity' requires knowing that this particular sequence received an automated InterPro-based odorant-binding annotation in UniProt, despite its experimentally confirmed role as a serpin-type coagulation inhibitor. No sequence-level reasoning independently justifies 'odorant binding' over the other options; the answer depends entirely on matching the protein to its specific database annotation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "B",
  "D"
]
```

> Option B (odorant binding) is the database IEA annotation. Option D (enzyme inhibitor activity, GO:0004857) is directly supported by experimental evidence (the protein inhibits factor XII activation). Both are defensible GO molecular function annotations for this protein. The question wording ('primary molecular function') arguably favors D, since the experimentally characterized primary activity is inhibition of F12, while odorant binding is an automated fold-similarity call with no functional validation.


### Important caveats

- The GO:0005549 annotation is IEA:InterPro (automated), not experimental. The experimentally validated function (ECO:0000269, IDA) is toxin activity / coagulation inhibition, not odorant binding.
- The author's expected answer matches a low-confidence computational annotation while contradicting the primary experimental evidence in the same database entry.
- The identity of the protein (L0MZ37, Ayaconin) was inferred from image-path metadata absent from the model input; the model sees only a 143-residue sequence.
- The benchmark's ground-truth construction methodology (whether it selects IEA annotations or only curated/experimental annotations) is unknown and affects whether this question tests prediction or annotation retrieval.
- The protein is a serpin-like coagulation pathway inhibitor from a sand fly; 'odorant binding' is likely a false-positive fold-similarity call by InterPro.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains a signal peptide and a ~120-residue mature domain. Without database lookup, a model reasoning from sequence features would identify serpin-like or lipocalin-like structural motifs. The experimental literature (PubMed:35817195) establishes this protein as a coagulation factor XII inhibitor, making 'enzyme inhibitor activity' (D) the biologically accurate answer. The 'odorant binding' label arises solely from an InterPro domain-similarity call (IEA), not from any observable odorant-binding motif in the sequence. No general biological reasoning from the raw sequence would preferentially select 'odorant binding' over 'enzyme inhibitor activity'; in fact, the opposite is more defensible.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific InterPro domain assignment that triggers the IEA:InterPro annotation of GO:0005549 for this exact sequence, and the knowledge that the benchmark authors used the database annotation (including low-confidence IEA entries) as the ground truth rather than the experimentally validated function.",
    "reason": "Selecting 'odorant binding' over 'enzyme inhibitor activity' requires knowing that this particular sequence received an automated InterPro-based odorant-binding annotation in UniProt, despite its experimentally confirmed role as a serpin-type coagulation inhibitor. No sequence-level reasoning independently justifies 'odorant binding' over the other options; the answer depends entirely on matching the protein to its specific database annotation."
  },
  "case_id": "GO_molecular_function_0052",
  "expected_answer_check": {
    "evidence_ids": [
      "C6",
      "H4",
      "C5",
      "H3",
      "C7",
      "H5"
    ],
    "judgment": "supported",
    "reason": "GO:0005549 (odorant binding) is annotated in UniProt entry L0MZ37 (evidence_id C6/H4). However, this annotation carries evidence code IEA:InterPro, meaning it is a purely computational inference from InterPro domain matching, not experimental evidence. The protein's experimentally validated molecular function (ECO:0000269, PubMed:35817195) is inhibition of coagulation factor XII activation, corresponding to GO:0090729 (toxin activity, IDA) and functionally to enzyme inhibitor activity (option D). The expected answer is technically present in the database but represents a low-confidence automated annotation that contradicts the experimentally determined function."
  },
  "important_caveats": [
    "The GO:0005549 annotation is IEA:InterPro (automated), not experimental. The experimentally validated function (ECO:0000269, IDA) is toxin activity / coagulation inhibition, not odorant binding.",
    "The author's expected answer matches a low-confidence computational annotation while contradicting the primary experimental evidence in the same database entry.",
    "The identity of the protein (L0MZ37, Ayaconin) was inferred from image-path metadata absent from the model input; the model sees only a 143-residue sequence.",
    "The benchmark's ground-truth construction methodology (whether it selects IEA annotations or only curated/experimental annotations) is unknown and affects whether this question tests prediction or annotation retrieval.",
    "The protein is a serpin-like coagulation pathway inhibitor from a sand fly; 'odorant binding' is likely a false-positive fold-similarity call by InterPro."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "B",
      "D"
    ],
    "reason": "Option B (odorant binding) is the database IEA annotation. Option D (enzyme inhibitor activity, GO:0004857) is directly supported by experimental evidence (the protein inhibits factor XII activation). Both are defensible GO molecular function annotations for this protein. The question wording ('primary molecular function') arguably favors D, since the experimentally characterized primary activity is inhibition of F12, while odorant binding is an automated fold-similarity call with no functional validation."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_molecular_function_0052",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "GO:0005549 (odorant binding) is annotated in UniProt entry L0MZ37 (evidence_id C6/H4). However, this annotation carries evidence code IEA:InterPro, meaning it is a purely computational inference from InterPro domain matching, not experimental evidence. The protein's experimentally validated molecular function (ECO:0000269, PubMed:35817195) is inhibition of coagulation factor XII activation, corresponding to GO:0090729 (toxin activity, IDA) and functionally to enzyme inhibitor activity (option D). The expected answer is technically present in the database but represents a low-confidence automated annotation that contradicts the experimentally determined function.",
    "evidence_ids": ["C6", "H4", "C5", "H3", "C7", "H5"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence contains a signal peptide and a ~120-residue mature domain. Without database lookup, a model reasoning from sequence features would identify serpin-like or lipocalin-like structural motifs. The experimental literature (PubMed:35817195) establishes this protein as a coagulation factor XII inhibitor, making 'enzyme inhibitor activity' (D) the biologically accurate answer. The 'odorant binding' label arises solely from an InterPro domain-similarity call (IEA), not from any observable odorant-binding motif in the sequence. No general biological reasoning from the raw sequence would preferentially select 'odorant binding' over 'enzyme inhibitor activity'; in fact, the opposite is more defensible.",
    "missing_item_specific_fact": "The specific InterPro domain assignment that triggers the IEA:InterPro annotation of GO:0005549 for this exact sequence, and the knowledge that the benchmark authors used the database annotation (including low-confidence IEA entries) as the ground truth rather than the experimentally validated function.",
    "reason": "Selecting 'odorant binding' over 'enzyme inhibitor activity' requires knowing that this particular sequence received an automated InterPro-based odorant-binding annotation in UniProt, despite its experimentally confirmed role as a serpin-type coagulation inhibitor. No sequence-level reasoning independently justifies 'odorant binding' over the other options; the answer depends entirely on matching the protein to its specific database annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["B", "D"],
    "reason": "Option B (odorant binding) is the database IEA annotation. Option D (enzyme inhibitor activity, GO:0004857) is directly supported by experimental evidence (the protein inhibits factor XII activation). Both are defensible GO molecular function annotations for this protein. The question wording ('primary molecular function') arguably favors D, since the experimentally characterized primary activity is inhibition of F12, while odorant binding is an automated fold-similarity call with no functional validation."
  },
  "important_caveats": [
    "The GO:0005549 annotation is IEA:InterPro (automated), not experimental. The experimentally validated function (ECO:0000269, IDA) is toxin activity / coagulation inhibition, not odorant binding.",
    "The author's expected answer matches a low-confidence computational annotation while contradicting the primary experimental evidence in the same database entry.",
    "The identity of the protein (L0MZ37, Ayaconin) was inferred from image-path metadata absent from the model input; the model sees only a 143-residue sequence.",
    "The benchmark's ground-truth construction methodology (whether it selects IEA annotations or only curated/experimental annotations) is unknown and affects whether this question tests prediction or annotation retrieval.",
    "The protein is a serpin-like coagulation pathway inhibitor from a sand fly; 'odorant binding' is likely a false-positive fold-similarity call by InterPro."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

### Source check 1

**Check:** `mixed_annotations_require_qualification`.

> C5/H3 describe blocking host factor-XII activation with ECO:0000269; C6/H4 carry odorant binding as IEA:InterPro, and C7 carries toxin activity IDA.

**Remaining uncertainty:** These sources support the stated biological inhibition role; assigning the alternative enzyme-inhibitor option and excluding odorant binding require interpretation beyond citation presence, and dual functions are not ruled out.

Evidence checked: [C5](#evidence-c5), [C6](#evidence-c6), [C7](#evidence-c7), [H3](#evidence-h3), [H4](#evidence-h4).

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `L0MZ37` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 24. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.
- Ontology names and EXACT synonyms match options mechanically; no answer-support judgment is made.
- Only is_a and part_of edges are used in supplied graph paths; all qualifiers and obsolete/replaced_by tags remain in literal source blocks.
- The ontology is newer than the benchmark repository commit; the exact author ontology snapshot is unknown.
- No matching term or path does not establish that an option is false.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/L0MZ37.json)  
**Locator:** `/comments/0`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:28:59.157851+00:00.  

```json
{"commentType":"FUNCTION","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"35817195","source":"PubMed"}],"value":"Inhibits the intrinsic blood coagulation pathway in the host by blocking activation of host coagulation factor XII (F12)"}]}
```

Source SHA-256: `e78c28c6e536e738f6d7b1eb5713d8f3bf3f0d3a564bf91f42ee8591e249894a`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/L0MZ37.json)  
**Locator:** `/uniProtKBCrossReferences/8`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:28:59.157851+00:00.  

```json
{"database":"GO","id":"GO:0005549","properties":[{"key":"GoTerm","value":"F:odorant binding"},{"key":"GoEvidenceType","value":"IEA:InterPro"}]}
```

Source SHA-256: `e78c28c6e536e738f6d7b1eb5713d8f3bf3f0d3a564bf91f42ee8591e249894a`.

### Evidence C7

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/L0MZ37.json)  
**Locator:** `/uniProtKBCrossReferences/9`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:28:59.157851+00:00.  

```json
{"database":"GO","evidences":[{"evidenceCode":"ECO:0000314","id":"35817195","source":"PubMed"}],"id":"GO:0090729","properties":[{"key":"GoTerm","value":"F:toxin activity"},{"key":"GoEvidenceType","value":"IDA:UniProtKB"}]}
```

Source SHA-256: `e78c28c6e536e738f6d7b1eb5713d8f3bf3f0d3a564bf91f42ee8591e249894a`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/L0MZ37?format=txt&versions=24)  
**Locator:** `lines 30-32`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 24 / 1.  
**Retrieved:** 2026-11-02T04:29:01.937579+00:00.  

```text
CC   -!- FUNCTION: Inhibits the intrinsic blood coagulation pathway in the host
CC       by blocking activation of host coagulation factor XII (F12).
CC       {ECO:0000269|PubMed:35817195}.
```

Source SHA-256: `d1e2af1800cc2394abd934a722dd73d429c29b573094e02cbd288087e7153333`.

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/L0MZ37?format=txt&versions=24)  
**Locator:** `lines 50-50`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 24 / 1.  
**Retrieved:** 2026-11-02T04:29:01.937579+00:00.  

```text
DR   GO; GO:0005549; F:odorant binding; IEA:InterPro.
```

Source SHA-256: `d1e2af1800cc2394abd934a722dd73d429c29b573094e02cbd288087e7153333`.

### Evidence H5

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/L0MZ37?format=txt&versions=24)  
**Locator:** `lines 51-51`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 24 / 1.  
**Retrieved:** 2026-11-02T04:29:01.937579+00:00.  

```text
DR   GO; GO:0090729; F:toxin activity; IDA:UniProtKB.
```

Source SHA-256: `d1e2af1800cc2394abd934a722dd73d429c29b573094e02cbd288087e7153333`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/GO_molecular_function.json), zero-based source row 52. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
